A focus on Genomics

Over the last years, onco-hematology was revolutionized by the discovery of numerous gene mutations involved in disease classification, prognosis and therapeutic indication. This unparalleled increase in the genomic knowledge related to hematological disorders was accompanied by an extension of the available techniques, but also by a dramatic increase in the required expertise to run those tests. At BARC, clinical trial testing is performed under the direction of our medical experts operating every day for medical testing with the most advanced hospitals. This brings BARC customers access to the most up-to-date knowledge for study design, testing, custom test development and implementation of companion tests into medical routine.